Jane Street Group, LLC Intellia Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $1.11 Million - $1.53 Million	56,100 New	56,100 $1.15 Million
Q1 2022 May 17, 2022	BUY	$58.27 - $118.99 $2.67 Million - $5.46 Million	45,900 Added 133.43%	80,300 $5.84 Million
Q4 2021 Feb 15, 2022	SELL	$100.76 - $138.36 $2.2 Million - $3.02 Million	-21,800 Reduced 38.79%	34,400 $4.07 Million
Q3 2021 Nov 16, 2021	SELL	$132.37 - $176.78 $16 Million - $21.3 Million	-120,600 Reduced 68.21%	56,200 $7.54 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $7.41 Million - $19.7 Million	121,700 Added 220.87%	176,800 $28.6 Million
Q1 2021 May 18, 2021	SELL	$46.59 - $83.68 $1.3 Million - $2.33 Million	-27,900 Reduced 33.61%	55,100 $4.42 Million
Q4 2020 Feb 17, 2021	BUY	$18.83 - $63.53 $1.56 Million - $5.27 Million	83,000 New	83,000 $4.52 Million

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.06B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.